Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65
Clinical trial NCT02389322 · COMPLETED
Trial details
- NCT number
- NCT02389322
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-07-01
- Enrollment
- 1044
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.